Anti-lubricin mAbs with defined epitopes, sensitivities, and specificities will be useful in diagnosing patients suspected of having CACP and in studying lubricin in patients and animal models affected by joint disease. This evidence concerns the gene PRG4 and camptodactyly-arthropathy-coxa vara-pericarditis syndrome.